Sexual Health Impact of Using Pre-exposure HIV Prophylaxis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05269199

Acronym

SatisPreP

Enrollment

Registered

2022-03-07

Start date

2022-04-01

Completion date

2023-03-12

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-exposure HIV Prophylaxis (PrEP)

Keywords

PrEP, MSM

Brief summary

Epidemiological and psychosociological survey of people on pre-exposure HIV prophylaxis (PrEP).

Detailed description

This study is perform to study the sexual health satisfaction of men who have sex with men (MSM), since the use pre-exposure HIV prophylaxis (PrEP), compared to the time before PrEP.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patient, male having sex with men, not infected with HIV, and using HIV prophylaxis by pre-exposure treatment (PrEP) for at least 1 year, received in consultation for renewal of this prescription. * Able to give his non-opposition to participate in the research. * Affiliation to a social security scheme.

Exclusion criteria

* Patient under curatorship/guardianship or safeguard of justice * Refusal to participate

Design outcomes

Primary

Measure	Time frame	Description
Sexual health satisfaction	1 day during the scheduled consultation	To study the sexual health satisfaction of men who have sex with men (MSM), since the use of HIV prophylaxis by pre-exposure treatment (PrEP), compared to the time before PrEP.

Secondary

Measure	Time frame	Description
Sentimental satisfaction	1 day during the scheduled consultation	To study the sentimental satisfaction since the use of HIV prophylaxis by treatment before exposure (PrEP), compared to the time before PrEP.
Risky behaviours	1 day during the scheduled consultation	To study risky behaviours without, then on PrEP since the use of HIV prophylaxis by treatment before exposure (PrEP), compared to the time before PrEP.
Specific care	1 day during the scheduled consultation	Describe the use of specific care during PrEP.
Predictors of satisfaction	1 day during the scheduled consultation	Define possible predictors of satisfaction with PrEP.

Countries

France

Outcome results